Ambeed.cn

首页 / 抑制剂/激动剂 / 其他抑制剂/激动剂 / / Alendronate sodium hydrate

阿仑膦酸钠 /Alendronate sodium hydrate {[allProObj[0].p_purity_real_show]}

货号:A136794 同义名: 阿仑膦酸钠三水合物 / Alendronate;MK 217

Alendronate Sodium Trihydrate is an inhibitor of farnesyl diphosphate synthase with IC50 of 460 nM. It is used to treat osteoporosis.

Alendronate sodium hydrate 化学结构 CAS号:121268-17-5
Alendronate sodium hydrate 化学结构
CAS号:121268-17-5
Alendronate sodium hydrate 3D分子结构
CAS号:121268-17-5
Alendronate sodium hydrate 化学结构 CAS号:121268-17-5
Alendronate sodium hydrate 3D分子结构 CAS号:121268-17-5
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Alendronate sodium hydrate 纯度/质量文件 产品仅供科研

货号:A136794 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nat. Biomed. Eng., 2024, 8, 1412-1424. Ambeed. [ A538667 , A631746 ]
JMC, 2024. Ambeed. [ A833302 , A475501 , A341986 , A356070 ]
BMC Cancer, 2024, 24(1): 1415. Ambeed. [ A809692 , A209020 ]
J. Am. Soc. Mass Spectrom., 2024, 35(12): 3192-3202. Ambeed. [ A166127 , A902473 , A753371 , A961334 , A292945 , A230770 , A300620 , A1114580 , A1159765 , A206238 ]
PloS One, 2024, 19(11): e0308060. Ambeed. [ A302917 ]
更多 >

Alendronate sodium hydrate 生物活性

描述 Farnesyl diphosphate synthase (FDPS), a key enzyme in isoprenoid biosynthesis, catalyzes the conversion of isopentenyl pyrophosphate and dimethylallyl pyrophosphate to geranyl pyrophosphate and farnesyl pyrophosphate, which are protein prenylation substrates[3]. Alendronate, a nitrogen-containing bisphosphonate, is an inhibitor of farnesyl diphosphate synthase with IC50 of 460 nM, used for the treatment and prevention of osteoporosis[4]. Women with low femoral-neck bone mineral density received alendronate therapy (initially 5 mg daily, increased to 10 mg daily at 24 months) showed lower frequency of morphometric and clinical vertebral fractures[5]. Patients with osteoporosis received 5 and 10 mg of alendronate per day showed increased bone density of the lumbar spine by 2.1 ± 0.3 percent and 2.9 ± 0.3 percent, respectively, in comparison with placebo group[6]. Alendronate at 60 and 100 μM completely suppressed squalestatin 1-mediated CYP2B mRNA induction that effectively inhibited cellular farnesyl diphosphate synthase activity, and also partially suppressed phenobarbital-inducible CYP2B expression[7].

Alendronate sodium hydrate 参考文献

[1]Bergstrom JD, Bostedor RG, et al. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys. 2000 Jan 1;373(1):231-41.

[2]Fisher JE, Rogers MJ, et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A. 1999 Jan 5;96(1):133-8.

[3]Kim HY, Kim DK, Bae SH, Gwak H, Jeon JH, Kim JK, Lee BI, You HJ, Shin DH, Kim YH, Kim SY, Han SS, Shim JK, Lee JH, Kang SG, Jang H. Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness. Exp Mol Med. 2018 Oct 17;50(10):1-12. doi: 10.1038/s12276-018-0166-2. PMID: 30333528; PMCID: PMC6193020.

[4]Bergstrom JD, Bostedor RG, Masarachia PJ, Reszka AA, Rodan G. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. Arch Biochem Biophys. 2000 Jan 1;373(1):231-41. doi: 10.1006/abbi.1999.1502. PMID: 10620343.

[5]Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Torner JC, Quandt SA, Reiss TF, Ensrud KE. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996 Dec 7;348(9041):1535-41. doi: 10.1016/s0140-6736(96)07088-2. PMID: 8950879.

[6]Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med. 1998 Jul 30;339(5):292-9. doi: 10.1056/NEJM199807303390502. PMID: 9682041.

[7]Jackson NM, Kocarek TA. Suppression of CYP2B induction by alendronate-mediated farnesyl diphosphate synthase inhibition in primary cultured rat hepatocytes. Drug Metab Dispos. 2008 Oct;36(10):2030-6. doi: 10.1124/dmd.108.022558. Epub 2008 Jul 10. PMID: 18617600; PMCID: PMC2559974.

Alendronate sodium hydrate 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.08mL

0.62mL

0.31mL

15.38mL

3.08mL

1.54mL

30.76mL

6.15mL

3.08mL

Alendronate sodium hydrate 技术信息

CAS号121268-17-5
分子式C4H18NNaO10P2
分子量 325.124
别名 阿仑膦酸钠三水合物 ;Alendronate;MK 217;Fosamax;Adronat;Alendronate (sodium hydrate);G-704650;Alendronate sodium trihydrate;G-704650 Adronat
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Inert atmosphere,Store in freezer, under -20°C

溶解度

H2O: 28 mg/mL(86.12 mM)

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。